These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11375214)

  • 1. Preventing exacerbations of chronic bronchitis and COPD.
    Ekberg-Jansson A; Larsson S; Löfdahl CG
    BMJ; 2001 May; 322(7297):1259-61. PubMed ID: 11375214
    [No Abstract]   [Full Text] [Related]  

  • 2. [Usefulness of mucoactive drugs in respiratory diseases].
    Serrano J; Sanchis J
    Arch Bronconeumol; 1998 Jan; 34(1):28-35. PubMed ID: 9522017
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mucolytics in acute and chronic respiratory tract disorders. II. Uses for treatment and antioxidant properties].
    Kupczyk M; Kuna P
    Pol Merkur Lekarski; 2002 Mar; 12(69):248-52. PubMed ID: 12053601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
    Teo E; House H; Lockhart K; Purchuri SN; Pushparajah J; Cripps AW; van Driel ML
    Cochrane Database Syst Rev; 2014 Sep; (9):CD010010. PubMed ID: 25201571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antioxidative features of ambroxol--usefulness in COPD].
    Nowak D
    Pneumonol Alergol Pol; 2001; 69(9-10):590-3. PubMed ID: 11928667
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review.
    Poole PJ; Black PN
    BMJ; 2001 May; 322(7297):1271-4. PubMed ID: 11375228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of N-acetylcysteine in the treatment of chronic obstructive pulmonary disease.
    van Herwaarden CL; Bast A; Dekhuijzen PN
    Neth J Med; 1995 Aug; 47(2):45-8. PubMed ID: 7566280
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis.
    Cazzola M; Rogliani P; Calzetta L; Hanania NA; Matera MG
    COPD; 2017 Oct; 14(5):552-563. PubMed ID: 28753070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidation pathway and exacerbations in COPD: the role of NAC.
    Matera MG; Calzetta L; Cazzola M
    Expert Rev Respir Med; 2016; 10(1):89-97. PubMed ID: 26567752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute exacerbations of chronic bronchitis: focusing management for optimum results.
    Aboussouan LS
    Postgrad Med; 1996 Apr; 99(4):89-90, 95-8, 101-2. PubMed ID: 8604417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled trial of ambroxol in chronic bronchitis.
    Guyatt GH; Townsend M; Kazim F; Newhouse MT
    Chest; 1987 Oct; 92(4):618-20. PubMed ID: 3308343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A controlled study on the action of a new formulation of ambroxol in asthmatiform bronchitis in children].
    Baldini G; Gucci M; Tarò D; Memmini C
    Minerva Pediatr; 1989 Feb; 41(2):91-5. PubMed ID: 2661989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of twelve-months therapy with oral ambroxol in preventing exacerbations in patients with COPD. Double-blind, randomized, multicenter, placebo-controlled study (the AMETHIST Trial).
    Malerba M; Ponticiello A; Radaeli A; Bensi G; Grassi V
    Pulm Pharmacol Ther; 2004; 17(1):27-34. PubMed ID: 14643168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.
    Poole PJ; Black PN
    Cochrane Database Syst Rev; 2000; (2):CD001287. PubMed ID: 10796634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [N-acetylcystein in the therapy of chronic bronchitis].
    Reichenberger F; Tamm M
    Pneumologie; 2002 Dec; 56(12):793-7. PubMed ID: 12486618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treating acute exacerbations of chronic bronchitis with N-acetylcysteine?].
    Behr J
    Pneumologie; 2002 Dec; 56(12):768-9. PubMed ID: 12486613
    [No Abstract]   [Full Text] [Related]  

  • 17. Mucolytic and antibiotic effect of a new compound in chronic bronchitis.
    Bŭrgi H
    Chemotherapy; 1975; 21(3-4):167-74. PubMed ID: 1098866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraluminal inflammation in the airways of patients with chronic bronchitis after treatment with Ambroxol.
    Lusuardi M; Capelli A; Salmona M; Tacconi MT; Cerutti CG; Donner CF
    Monaldi Arch Chest Dis; 1995 Oct; 50(5):346-51. PubMed ID: 8541815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemophilus influenzae oral whole cell vaccination for preventing acute exacerbations of chronic bronchitis.
    Foxwell AR; Cripps AW; Dear KB
    Cochrane Database Syst Rev; 2003; (3):CD001958. PubMed ID: 12917917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucolytics and antioxidant activity.
    Strapková A; Nosál'ová G; Franová S
    Life Sci; 1999; 65(18-19):1923-5. PubMed ID: 10576438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.